Week in Review: Hua Medicine Approved for $200 Million Hong Kong IPO
June 09, 2018 at 17:46 PM EDT
Hua Medicine, a Beijing biopharma, announced its IPO application was accepted by the Hong Kong exchange. According to rumors, the company hopes to raise $200 million in the offering.
